Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate incremental cost effectiveness of
Nifedipine CR and Amlodipine in combination therapy with Valsartan for the treatment of
essential hypertensive patients.
To investigate incremental cost effectiveness, primary variables are mean treatment cost and
achievement rate to target blood pressure level at the end of double-blind treatment period.